Display options
Share it on

Allergy Rhinol (Providence). 2015 Jan;6(1):33-8. doi: 10.2500/ar.2015.6.0107. Epub 2015 Feb 11.

Changes of micro-RNAs in asymptomatic subjects sensitized to Japanese cedar pollen after prophylactic sublingual immunotherapy.

Allergy & rhinology (Providence, R.I.)

Bo Hou, Mariko Murata, Ahmad Shah Said, Hiroshi Sakaida, Sawako Masuda, Taiki Takahashi, Zhe Zhang, Kazuhiko Takeuchi

Affiliations

  1. Department of Otorhinolaryngology, Head and Neck Surgery, Mie University Graduate School of Medicine, Tsu, Japan.

PMID: 25675113 PMCID: PMC4388874 DOI: 10.2500/ar.2015.6.0107

Abstract

Japanese cedar pollinosis is the predominant seasonal allergic rhinitis in Japan, and it has increased in prevalence during the past 10 years. Sublingual immunotherapy (SLIT) is considered a safe and effective treatment for pollinosis. Micro-RNAs (miRNAs) are a class of short single-stranded RNA molecules that posttranscriptionally silence gene expression and may mediate allergic immune responses. The aim of this study was to investigate the miRNA alteration in asymptomatic subjects sensitized to Japanese cedar pollen under prophylactic SLIT under part of a randomized, double-blind, placebo-controlled, multiple-center trial. Analysis was undertaken in 15 asymptomatic subjects sensitized to Japanese cedar pollen-specific IgE (ImmunoCAP class ≥2) who participated in 2013. The SLIT group (n = 6) received standardized Japanese cedar pollen extract and the placebo group (n = 9) received an inactive placebo for 5 months covering the cedar pollen season. Changes in serum miRNAs were measured by real-time quantitative polymerase chain reaction to determine whether SLIT had effects on profiles of circulating miRNA. Seven subjects in the placebo group developed pollinosis symptoms, whereas no subjects in the SLIT group did (p = 0.007). Serum hsa-miR-223 was significantly up-regulated in postseason compared with preseason samples. The hsa-let-7b was significantly more down-regulated in postseason than in preseason samples from the placebo group; however, no significant differences were observed in those from the SLIT group. A significant decrease in circulating let-7b was also observed in the subjects who developed symptoms. Prophylactic SLIT was effective in preventing the development of pollinosis. Alterations in miRNA expression occurred in asymptomatic, sensitized subjects during cedar pollen season.

References

  1. Allergol Int. 2009 Jun;58(2):155-62 - PubMed
  2. Am J Clin Exp Immunol. 2012 Nov 15;1(2):154-65 - PubMed
  3. Immunol Allergy Clin North Am. 2011 May;31(2):311-23, x - PubMed
  4. Allergol Int. 2011 Mar;60(2):171-89 - PubMed
  5. Int Arch Allergy Immunol. 2010;153(4):378-87 - PubMed
  6. J Allergy Clin Immunol. 2013 Jul;132(1):3-13; quiz 14 - PubMed
  7. Clin Immunol. 2011 Apr;139(1):65-74 - PubMed
  8. J Allergy Clin Immunol. 2011 Jul;128(1):160-167.e4 - PubMed
  9. RNA. 2013 Nov;19(11):1552-62 - PubMed
  10. J Allergy Clin Immunol. 2012 Apr;129(4):1064-75.e9 - PubMed
  11. Annu Rev Immunol. 2012;30:295-312 - PubMed
  12. J Allergy Clin Immunol. 2014 Feb;133(2):543-50 - PubMed
  13. Clin Exp Allergy. 2009 Sep;39(9):1314-23 - PubMed
  14. Nat Rev Immunol. 2006 Oct;6(10):761-71 - PubMed
  15. J Allergy Clin Immunol. 2003 Nov;112(5):915-22 - PubMed
  16. Allergol Int. 2015 Jan;64(1):54-9 - PubMed
  17. Am J Rhinol Allergy. 2014 Mar-Apr;28(2):131-9 - PubMed
  18. Ann Allergy Asthma Immunol. 2011 May;106(5):355-61; quiz 362 - PubMed
  19. Allergy. 2008 Apr;63 Suppl 86:8-160 - PubMed
  20. J Allergy Clin Immunol. 2011 Nov;128(5):1077-85.e1-10 - PubMed
  21. Am J Rhinol Allergy. 2012 Mar-Apr;26(2):92-6 - PubMed
  22. Am J Respir Crit Care Med. 2008 Mar 15;177(6):567-73 - PubMed
  23. Arerugi. 2001 Jun;50(6):520-7 - PubMed
  24. J Allergy Clin Immunol Pract. 2013 May-Jun;1(3):228-41 - PubMed
  25. Microbes Infect. 2005 Jun;7(7-8):990-6 - PubMed
  26. J Allergy Clin Immunol. 2009 Oct;124(4):842-5.e7 - PubMed

Publication Types